N-(6-Chloro-7H-purin-2-yl)acetamide

Catalog No. :
ACGWOM824
CAS No. :
7602-01-9
Molecular Formula :
C7H6ClN5O
Molecular Weight :
211.61

IUPAC Name:N-(6-chloro-7H-purin-2-yl)acetamide

N-(6-Chloro-7H-purin-2-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$74.00Login to see priceIn stockInquiry
5g97%$203.00Login to see priceIn stockInquiry
25g97%$914.00Login to see priceIn stockInquiry
100g97%$3546.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(6-Chloro-7H-purin-2-yl)acetamide
IUPAC NameN-(6-chloro-7H-purin-2-yl)acetamide
MDL No.MFCD00823609
Molecular FormulaC7H6ClN5O
Molecular Weight211.61
SMILESCC(=O)NC1=NC2=C(NC=N2)C(Cl)=N1
InChI KeyRZZCIBFHZYEENN-UHFFFAOYSA-N
SynonymCS-0067220 | 2-(ACETYLAMINO)-6-CHLOROPURINE | A915106 | DTXSID60997366 | N-(6-chloro-9H-purin-2-yl)acetamide | 2-acetylamino-6-chloro-9h-purine | 5-Pyrimidinecarbonitrile, 1,6-dihydro-2-(methylthio)-6-oxo- | AKOS037621661 | 2-acetamido-6-chloropurine | W-
CAS No.7602-01-9
PubChem CID6098997

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACGWOM824 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIGFL096 route compound structure diagram
    ACIGFL09610310-21-1 In Stock
  4. Then
  5. ACGWOM824 route product structure diagram
    ACGWOM8247602-01-9 In Stock
Inquiry

2. ACGWOM824 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIGFL096 route compound structure diagram
    ACIGFL09610310-21-1 In Stock
  4. Then
  5. ACGWOM824 route product structure diagram
    ACGWOM8247602-01-9 In Stock
Inquiry

Comments (0)